[{"id":"39342328-ad97-49d3-96fc-e5d5951b2e47","acronym":"","url":"https://clinicaltrials.gov/study/NCT05554575","created_at":"2022-09-26T14:56:13.019Z","updated_at":"2024-07-02T16:36:03.469Z","phase":"Phase 1","brief_title":"Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL","source_id_and_acronym":"NCT05554575","lead_sponsor":"Bioceltech Therapeutics, Ltd.","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BT-007"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 09/01/2024","primary_completion_date":" 09/01/2024","study_txt":" Completion: 09/01/2024","study_completion_date":" 09/01/2024","last_update_posted":"2022-09-26"}]